For the year ending 2025-12-31, BHC made $10,266M in revenue. $157M in net income. Net profit margin of 1.53%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenues | 10,266 | 9,625 | ||
| Cost of goods sold (excluding amortization and impairments of intangible assets) and cost of other revenues-Product | 2,949 | - | ||
| Cost of goods sold (excluding amortization and impairments of intangible assets) and cost of other revenues-Product And Service Other | 64 | - | ||
| Selling, general and administrative | 3,438 | 3,296 | ||
| Research and development | 629 | 616 | ||
| Amortization of intangible assets | 1,001 | 1,077 | ||
| Goodwill impairments | 145 | - | ||
| Asset impairments | 8 | 29 | ||
| Restructuring, integration and separation costs | 77 | 32 | ||
| Cost of goods sold (excluding amortization and impairments of intangible assets) and cost of other revenues | - | 2,729 | ||
| Other expense, net | -142 | -247 | ||
| Total expenses | 8,453 | 8,079 | ||
| Operating income | 1,813 | 1,546 | ||
| Interest income | 48 | 33 | ||
| Interest expense | 1,604 | 1,388 | ||
| Gain on extinguishment of debt | 162 | 23 | ||
| Foreign exchange and other | -52 | -47 | ||
| Income (loss) before income taxes | 367 | 167 | ||
| Provision for income taxes | 247 | 239 | ||
| Net income (loss) | 120 | -72 | ||
| Net loss attributable to noncontrolling interest | -37 | -26 | ||
| Net income (loss) attributable to bausch health companies inc | 157 | -46 | ||
| Basic (in dollars per share) | 0.42 | -0.13 | ||
| Basic (in shares) | 370,900,000 | 368,000,000 | ||
| Diluted (in dollars per share) | 0.42 | -0.13 | ||
| Diluted (in shares) | 375,000,000 | 368,000,000 | ||
Bausch Health Companies Inc. (BHC)
Bausch Health Companies Inc. (BHC)